ADLS NASDAQ

ADLS, (NASDAQ: ADLS) Advanced Life Sciences Holdings, Inc. is a solid company that is currently in the health care of the biotechnology industry. The shares opened up / down about 35% and is now trading at 0.02, which represents a change of 12.5%. Advanced Life Sciences Holdings, Inc. has a market capital of 0.83M, which is a good amount of shares in the industry. With 41.59M shares outstanding and a float of 30.80M alone, this company is ready to move. In addition, the company has done very well today as the stock trades at a volume of 1155100 compared to its average daily volume of 3.76 m shares. Today, ADLS is trading with a gain of -16.67% from its opening this morning.Over the last 52 weeks ADLS did much as they are 55% below its 52-week and 125% above its 52 weeks low.
Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. Company’s main candidate, Restanza, is a novel once-daily oral antibiotic in late-stage development for the treatment of life-threatening infections such as pneumonia and bacterial community aquired biodefense pathogens, including anthrax, plague and tularemia.